Lucid Diagnostics Inc. (LUCD) stock
LUCDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/3034% above fair value
$0.40+0.00 (+0.30%)
Close on Nov 17, 2026Market cap $81.09MP/E –Yield –
Lucid Diagnostics gross margin
Gross margin is gross profit as a percentage of revenue.
Lucid Diagnostics's gross margin for the twelve months ending Dec 31, 2022 was 100.0%. For fiscal 2025 it was -41.7%, against -63.3% the year before.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -41.7% | +21.6 |
| FY2024 | Dec 31, 2024 | -63.3% | −163.3 |
| FY2022 | Dec 31, 2022 | 100.0% | +0.0 |
| FY2021 | Dec 31, 2021 | 100.0% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 2.0% | −98.0 |
| Q1 FY2026 | Mar 31, 2026 | -29.4% | −129.4 |
| Q2 FY2025 | Jun 30, 2025 | -34.4% | +60.8 |
| Q1 FY2025 | Mar 31, 2025 | -87.3% | −187.3 |
| Q4 FY2022 | Dec 31, 2022 | 100.0% | +0.0 |
| Q3 FY2022 | Sep 30, 2022 | 100.0% | – |
| Q1 FY2022 | Mar 31, 2022 | -95.2% | – |
| Q4 FY2021 | Dec 31, 2021 | 100.0% | – |
| Q3 FY2021 | Sep 30, 2021 | 100.0% | – |
See a number that looks wrong?